Antibiotic Resistance: What is there in Past, Present and Future?
1★★ Corresponding author
- 1Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Karaikal, Puducherry, INDIA.
CORRESPONDENCE
Raman Palanisamy Priyadharsini
Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Karaikal, Puducherry, INDIA.
Received: 25-07-2019; Revised: 30-08-2019; Accepted: 24-09-2019.
Volume 11, Issue 4 · pp. 333-336 · 2019 · DOI: 10.5530/jyp.2019.11.69
ABSTRACT
The burden of the resistance to the antibiotics increases day by day and there is a high chance that even minor infections can kill patients in future. There is a high resistance to third generation cephalosporins and fluoroquinolones among Acinietobacter baumanni, Escherchia coli, Klebsiella pneumonia and Pseudomonas aeruginosa. The carbapenam resistance is also increasing among these bacteria. The colistin is the drug used in the treatment of carbapenam resistance and the colistin resistance also has increased. CDSCO has restricted the use of higher antibiotics carbapenams class III and IV for resistant infections. The factors influencing antibiotic resistance are many and WHO has recommended strategies to decrease the mortality and morbidity of antibiotic resistance.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Priyadharsini, R. P. (2019). Antibiotic Resistance: What is there in Past, Present and Future?. Journal of Young Pharmacists, 11(4), 333-336. https://doi.org/10.5530/jyp.2019.11.69
Copyright and licence
© 2019 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0